Dr. Reddy’s Laboratories announced the launch of Montelukast Sodium Oral Granules, the generic version of Merck‘s Singulair oral granules.

Montelukast Sodium, a leukotriene antagonist, is indicated for the treatment of seasonal allergic rhinitis (for patients ≥2 years old), and perennial allergic rhinitis (for patients ≥6 months old). Also, it is indicated for the prophylaxis and chronic treatment of asthma (for patients ≥12 months old), and prevention of exercise-induced bronchoconstriction (EIB) (for patients ≥15 years old).

Montelukast Sodium Oral Granules are available as a 4mg strength in 30-count unit dose packages.

For more information call (908) 203-4933 or visit www.drreddys.com.